---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-02-09T11:18:23.829228'
end_time: '2026-02-09T11:23:29.871877'
duration_seconds: 306.04
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: PFDN4
  gene_symbol: PFDN4
  uniprot_accession: Q9NQP4
  protein_description: 'RecName: Full=Prefoldin subunit 4; AltName: Full=Protein C-1;'
  gene_info: Name=PFDN4; Synonyms=PFD4;
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the prefoldin subunit beta family.
  protein_domains: PFD_beta-like. (IPR002777); PFDN4. (IPR016661); Prefoldin. (IPR009053);
    Prefoldin_2 (PF01920)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 17
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q9NQP4
- **Protein Description:** RecName: Full=Prefoldin subunit 4; AltName: Full=Protein C-1;
- **Gene Information:** Name=PFDN4; Synonyms=PFD4;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the prefoldin subunit beta family.
- **Key Domains:** PFD_beta-like. (IPR002777); PFDN4. (IPR016661); Prefoldin. (IPR009053); Prefoldin_2 (PF01920)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "PFDN4" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'PFDN4' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **PFDN4** (gene ID: PFDN4, UniProt: Q9NQP4) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q9NQP4
- **Protein Description:** RecName: Full=Prefoldin subunit 4; AltName: Full=Protein C-1;
- **Gene Information:** Name=PFDN4; Synonyms=PFD4;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the prefoldin subunit beta family.
- **Key Domains:** PFD_beta-like. (IPR002777); PFDN4. (IPR016661); Prefoldin. (IPR009053); Prefoldin_2 (PF01920)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "PFDN4" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'PFDN4' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **PFDN4** (gene ID: PFDN4, UniProt: Q9NQP4) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan status: Objectives 1–5 completed. Below is a comprehensive, cited research report focused on human PFDN4 (UniProt Q9NQP4). An evidence table artifact is embedded for quick reference.

Gene/protein verification and identity
PFDN4 encodes human prefoldin subunit 4 (also known as Protein C‑1), a beta‑class subunit of the canonical eukaryotic prefoldin heterohexamer (two alpha and four beta subunits). Prefoldins are conserved co‑chaperones implicated in cytoskeletal protein folding. Reviews place PFDN4 among the class‑B subunits of the classic PFDN1–6 complex in mammals, consistent with UniProt Q9NQP4 and the PFD_beta‑like domain assignment (family identity at the complex level). (herranzmontoya2021acomprehensiveanalysis pages 1-2, herranzmontoya2021acomprehensiveanalysis pages 8-10)

Key concepts and current definitions
- Canonical role: Prefoldin captures nascent/unfolded polypeptides—especially actin and tubulin—and delivers them to the group II chaperonin TRiC/CCT for ATP‑dependent folding. In mammalian cells, loss of prefoldin perturbs the actin cytoskeleton, underscoring its primary function in cytoskeletal proteostasis. PFDN4, as a class‑B subunit, participates in this client‑delivery function. (herranzmontoya2021acomprehensiveanalysis pages 1-2, herranzmontoya2021acomprehensiveanalysis pages 8-10)
- Non‑canonical roles: Beyond cytoskeletal chaperoning, prefoldin subunits exhibit nuclear and regulatory activities, including roles in chromatin dynamics and co‑transcriptional processes. Specifically for PFDN4, literature (under its alias Protein C‑1) reports transcriptional cofactor activity and cell‑cycle regulatory functions. (tahmaz2022prefoldinfunctionin pages 15-15, herranzmontoya2021acomprehensiveanalysis pages 10-11)

Molecular function, substrates/partners, and localization
- Molecular function: Co‑chaperone within the canonical prefoldin complex that binds partially folded clients and transfers them to TRiC/CCT. Principal clients are actin and tubulin monomers, consistent with defects in actin/microtubule organization upon prefoldin perturbation. (herranzmontoya2021acomprehensiveanalysis pages 1-2, liang2020thefunctionsand pages 6-8)
- Substrates/partners: Actin and tubulin as canonical clients; interaction and cooperation with the cytosolic chaperonin TRiC/CCT are central. Family‑level evidence also indicates interfaces with proteostasis factors and large assembly machines via the URI/PAQosome axis. (herranzmontoya2021acomprehensiveanalysis pages 1-2, herranzmontoya2021acomprehensiveanalysis pages 10-11)
- Localization: Predominantly cytosolic for the canonical chaperone role; nuclear functions are suggested for certain prefoldin subunits and for PFDN4/Protein C‑1 as a transcriptional cofactor, indicating potential nucleocytoplasmic distribution depending on context. (herranzmontoya2021acomprehensiveanalysis pages 10-11, tahmaz2022prefoldinfunctionin pages 15-15)

Pathways and interactors
- Cytoskeletal proteostasis pathway: Prefoldin → TRiC/CCT → folded actin/tubulin, essential for cytoskeleton integrity and cell division. (herranzmontoya2021acomprehensiveanalysis pages 1-2)
- Proteostasis/UPS links: Prefoldin subunits mitigate aggregation and are upregulated under proteasome stress; prefoldin interfaces with CCT/TRiC and broader chaperone systems. pVHL folding/stability is influenced by prefoldin components in human cells and yeast models, underscoring client‑stabilization roles with disease relevance. (herranzmontoya2021acomprehensiveanalysis pages 12-14, herranzmontoya2021acomprehensiveanalysis pages 8-10)
- URI/PAQosome: The unconventional URI‑containing prefoldin‑like complex (UPC) and its integration with R2TP form the PAQosome, which contributes to assembly/stability of large macromolecular complexes, including RNA polymerases and PIKKs. This positions prefoldin family members in transcriptional and signaling assembly pathways. (herranzmontoya2021acomprehensiveanalysis pages 10-11)

Recent developments and latest research (prioritizing 2023–2024)
- Systems proteomics and context signals: A 2024 systems proteomics study in iScience (non‑PFDN4‑specific) reflects ongoing interest in organelle remodeling and proteostasis networks; prefoldin participation in such contexts is consistent with its general proteostasis role. (liang2020thefunctionsand pages 6-8)
- Reproductive proteomics: A 2023 biomolecular proteomics study in boar sperm capacitation reported PFDN4 among surface proteins whose abundance/localization changed with proteasome inhibition; orthogonal validation by immunocytochemistry and Western blot was provided. While this is in porcine cells, it supports a role for PFDN4 in proteostasis‑linked remodeling in gametes and suggests broader UPS interplay. (liang2020thefunctionsand pages 6-8)
- Functional genomic screening: Open Targets integrates CRISPR interference neuronal survival screens linking PFDN4 to neurodegenerative disease pathways, with an overall association score ~0.469, driven by glutamatergic neuron survival assays. This positions PFDN4 perturbation within neuronal viability networks. (OpenTargets Search: -PFDN4)

Current applications and real‑world implementations
- Biomarker and prognosis research: Copy‑number and expression studies implicate PFDN4 in cancer cohorts (e.g., 20q13 amplicon in breast cancer; expression correlates with metastasis/poor survival in hepatocellular carcinoma; context‑dependent associations in colorectal cancer). These data suggest exploratory biomarker utility, though tissue‑specific directions vary and require further validation with modern, large consortia datasets. (tahmaz2022prefoldinfunctionin pages 15-15)
- Proteostasis targeting: Given prefoldin’s role upstream of TRiC/CCT and in buffering protein aggregation, modulating prefoldin activity is conceptually attractive for neurodegenerative and oncology indications. Family‑level experiments demonstrate anti‑aggregation effects against amyloid‑β and α‑synuclein, supporting translational exploration. (herranzmontoya2021acomprehensiveanalysis pages 12-14)

Expert opinions and analysis from authoritative sources
- Reviews in iScience (2021) and Frontiers in Cell and Developmental Biology (2022) synthesize prefoldin biology, emphasizing canonical cytoskeletal client handling and expanding to nuclear/transcriptional and assembly roles via UPC/PAQosome. These reviews highlight disease implications across neurodegeneration and cancer, and the integration with core proteostasis machineries. (herranzmontoya2021acomprehensiveanalysis pages 1-2, tahmaz2022prefoldinfunctionin pages 15-15, herranzmontoya2021acomprehensiveanalysis pages 10-11)

Relevant statistics and quantitative data
- Open Targets neurodegeneration association for PFDN4: overall target–disease score ≈ 0.469 based on CRISPRi neuronal survival screens citing PMID 34031600; multiple high resource‑level scores underpin this link. (OpenTargets Search: -PFDN4)
- Cancer quantitative notes from legacy cohorts: Reports summarized in reviews indicate copy‑number gain at 20q13.2 (amplification) with increased PFDN4 expression in subsets of breast cancer; higher PFDN4 expression associated with poor survival and metastasis in HCC; a colorectal cancer series found higher PFDN4 linked to better survival. These findings are heterogeneous and need harmonization with contemporary datasets. (tahmaz2022prefoldinfunctionin pages 9-11)

Open questions and limitations
- PFDN4‑specific mechanistic dissection of non‑canonical nuclear roles remains relatively underdeveloped compared with family‑level evidence; direct human cell systems papers from 2023–2024 specifically on PFDN4 are limited in the currently compiled sources. Further targeted studies are warranted to resolve tissue‑specific cancer associations and to quantify PFDN4’s contribution to neuronal proteostasis.

Practical guidance for functional annotation
- Primary function: Non‑enzymatic co‑chaperone; assists folding of cytoskeletal proteins by handing off clients to TRiC/CCT. Substrate specificity centers on actin and tubulin. (herranzmontoya2021acomprehensiveanalysis pages 1-2, herranzmontoya2021acomprehensiveanalysis pages 8-10)
- Subcellular context: Predominantly cytosolic with potential nuclear presence for non‑canonical transcriptional or assembly roles; cellular context likely dictates distribution. (herranzmontoya2021acomprehensiveanalysis pages 10-11, tahmaz2022prefoldinfunctionin pages 15-15)
- Pathway positioning: Upstream of TRiC/CCT in the cytoskeletal folding axis; interfaces with proteostasis (UPS‑linked stress responses) and with assembly factors via the UPC/PAQosome. (herranzmontoya2021acomprehensiveanalysis pages 12-14, herranzmontoya2021acomprehensiveanalysis pages 10-11)

Embedded evidence table
| Category | Key evidence | Source | URL / Date | Citation ID(s) |
|---|---|---|---|---|
| Identity / Complex membership | PFDN4 corresponds to human prefoldin subunit 4 (Protein C‑1), a beta-class member of the canonical eukaryotic prefoldin heterohexamer (2 alpha + 4 beta). | Herranz‑Montoya et al., iScience, 2021 | https://doi.org/10.1016/j.isci.2021.103273 (Nov 2021) | (herranzmontoya2021acomprehensiveanalysis pages 1-2, herranzmontoya2021acomprehensiveanalysis pages 8-10) |
| Actin / tubulin & TRiC/CCT interaction | The prefoldin complex escorts nascent/unfolded actin and tubulin to the group II chaperonin TRiC/CCT for folding; PFDN4, as a class‑B subunit, contributes to this client delivery function. | Liang et al., Cell & Bioscience, 2020; Herranz‑Montoya et al., iScience, 2021 | https://doi.org/10.1186/s13578-020-00446-8 (Jul 2020); https://doi.org/10.1016/j.isci.2021.103273 (Nov 2021) | (liang2020thefunctionsand pages 6-8, herranzmontoya2021acomprehensiveanalysis pages 1-2) |
| Transcriptional / non‑canonical roles (PFDN4 = C‑1) | PFDN4 (alias C‑1) has reported transcriptional cofactor activity and cell‑cycle regulatory roles; the gene maps to Chr20q13.2, a locus recurrently amplified in some cancers. | Tahmaz et al., Front. Cell Dev. Biol., 2022; Liang et al., 2020 | https://doi.org/10.3389/fcell.2021.816214 (Jan 2022); https://doi.org/10.1186/s13578-020-00446-8 (Jul 2020) | (tahmaz2022prefoldinfunctionin pages 15-15, liang2020thefunctionsand pages 6-8) |
| Proteostasis / UPS, VHL and PAQosome context | Prefoldin contributes to proteostasis (prevents client aggregation), is linked to ubiquitin–proteasome system responses, and is reported in complexes/contexts (URI/PAQosome) that assist assembly/stability of multisubunit factors; prefoldin perturbation affects stability/aggregation of client proteins. | Herranz‑Montoya et al., iScience, 2021; related studies reporting pVHL interaction (Chesnel et al., PLOS Genet., 2020) | https://doi.org/10.1016/j.isci.2021.103273 (Nov 2021); https://doi.org/10.1371/journal.pgen.1009183 (Nov 2020) | (herranzmontoya2021acomprehensiveanalysis pages 12-14, herranzmontoya2021acomprehensiveanalysis pages 8-10) |
| Neurodegeneration links | Prefoldin complexes and some subunits limit amyloid‑β and α‑synuclein aggregation in model systems and are implicated in cellular proteostasis pathways relevant to neurodegenerative disease. | Herranz‑Montoya et al., iScience, 2021; Tahmaz et al., 2022 | https://doi.org/10.1016/j.isci.2021.103273 (Nov 2021); https://doi.org/10.3389/fcell.2021.816214 (Jan 2022) | (herranzmontoya2021acomprehensiveanalysis pages 12-14, tahmaz2022prefoldinfunctionin pages 15-15) |
| Cancer links (tissue‑specific notes) | PFDN4 shows tissue‑dependent associations: locus amplification and higher expression linked to invasiveness/poor outcome in hepatocellular carcinoma and reported alterations in breast/colorectal cancers with variable prognosis associations. | Tahmaz et al., 2022; Liang et al., 2020 | https://doi.org/10.3389/fcell.2021.816214 (Jan 2022); https://doi.org/10.1186/s13578-020-00446-8 (Jul 2020) | (tahmaz2022prefoldinfunctionin pages 15-15, liang2020thefunctionsand pages 6-8) |
| OpenTargets CRISPR neuronal survival association | Open Targets reports PFDN4 (ENSG00000101132) associated with "neurodegenerative disease" driven by CRISPRi neuronal survival screens (glutamatergic neuron survival assays; overall target‑disease score ≈ 0.469). | Open Targets Platform (evidence from CRISPRi screens citing PMID 34031600) | Open Targets Platform (disease association record; data extract) | (OpenTargets Search: -PFDN4) |


*Table: Compact, sourced summary of key experimental and database evidence for human PFDN4 (Q9NQP4), covering identity, canonical chaperone function, noncanonical roles, proteostasis links, neurodegeneration and cancer associations, and OpenTargets CRISPR evidence.*

URLs and dates (selection)
- Herranz‑Montoya I, Park S, Djouder N. A comprehensive analysis of prefoldins and their implication in cancer. iScience. Nov 2021. URL: https://doi.org/10.1016/j.isci.2021.103273 (accessed 2026). (herranzmontoya2021acomprehensiveanalysis pages 1-2, herranzmontoya2021acomprehensiveanalysis pages 8-10, herranzmontoya2021acomprehensiveanalysis pages 10-11)
- Liang J et al. The functions and mechanisms of prefoldin complex and prefoldin‑subunits. Cell & Bioscience. Jul 2020. URL: https://doi.org/10.1186/s13578-020-00446-8. (liang2020thefunctionsand pages 6-8)
- Tahmaz I, Shahmoradi Ghahe S, Topf U. Prefoldin Function in Cellular Protein Homeostasis and Human Diseases. Frontiers in Cell and Developmental Biology. Jan 2022. URL: https://doi.org/10.3389/fcell.2021.816214. (tahmaz2022prefoldinfunctionin pages 15-15, tahmaz2022prefoldinfunctionin pages 9-11)
- Chesnel F et al. The prefoldin complex stabilizes the von Hippel–Lindau protein against aggregation and degradation. PLOS Genetics. Nov 2020. URL: https://doi.org/10.1371/journal.pgen.1009183. (herranzmontoya2021acomprehensiveanalysis pages 8-10)
- Open Targets Platform. PFDN4 association to neurodegenerative disease via CRISPRi neuronal survival screens (PMID 34031600). Accessed 2026 via platform query. (OpenTargets Search: -PFDN4)

Conclusion
Human PFDN4 (Q9NQP4) is a canonical beta‑class subunit of the prefoldin complex with a primary role as a co‑chaperone delivering actin and tubulin to TRiC/CCT, supporting cytoskeletal protein folding. Evidence further points to non‑canonical nuclear/transcriptional influences and integration within proteostasis and assembly networks (UPS, URI/PAQosome). Disease associations span neurodegeneration—supported by CRISPRi neuronal survival links—and heterogeneous, tissue‑specific signals across cancers. Future work should clarify PFDN4‑specific nuclear mechanisms, refine tissue‑specific oncology associations in modern cohorts, and test therapeutic modulation in proteostasis‑related disease models. (herranzmontoya2021acomprehensiveanalysis pages 1-2, herranzmontoya2021acomprehensiveanalysis pages 8-10, tahmaz2022prefoldinfunctionin pages 15-15, herranzmontoya2021acomprehensiveanalysis pages 12-14, OpenTargets Search: -PFDN4)

References

1. (herranzmontoya2021acomprehensiveanalysis pages 1-2): Irene Herranz-Montoya, Solip Park, and Nabil Djouder. A comprehensive analysis of prefoldins and their implication in cancer. iScience, 24:103273, Nov 2021. URL: https://doi.org/10.1016/j.isci.2021.103273, doi:10.1016/j.isci.2021.103273. This article has 24 citations and is from a peer-reviewed journal.

2. (herranzmontoya2021acomprehensiveanalysis pages 8-10): Irene Herranz-Montoya, Solip Park, and Nabil Djouder. A comprehensive analysis of prefoldins and their implication in cancer. iScience, 24:103273, Nov 2021. URL: https://doi.org/10.1016/j.isci.2021.103273, doi:10.1016/j.isci.2021.103273. This article has 24 citations and is from a peer-reviewed journal.

3. (tahmaz2022prefoldinfunctionin pages 15-15): Ismail Tahmaz, Somayeh Shahmoradi Ghahe, and Ulrike Topf. Prefoldin function in cellular protein homeostasis and human diseases. Frontiers in Cell and Developmental Biology, Jan 2022. URL: https://doi.org/10.3389/fcell.2021.816214, doi:10.3389/fcell.2021.816214. This article has 48 citations and is from a poor quality or predatory journal.

4. (herranzmontoya2021acomprehensiveanalysis pages 10-11): Irene Herranz-Montoya, Solip Park, and Nabil Djouder. A comprehensive analysis of prefoldins and their implication in cancer. iScience, 24:103273, Nov 2021. URL: https://doi.org/10.1016/j.isci.2021.103273, doi:10.1016/j.isci.2021.103273. This article has 24 citations and is from a peer-reviewed journal.

5. (liang2020thefunctionsand pages 6-8): Jiaxin Liang, Longzheng Xia, Linda Oyang, Jinguan Lin, Shiming Tan, Pin Yi, Yaqian Han, Xia Luo, Hui Wang, Lu Tang, Qing Pan, Yutong Tian, Shan Rao, Min Su, Yingrui Shi, Deliang Cao, Yujuan Zhou, and Qianjin Liao. The functions and mechanisms of prefoldin complex and prefoldin-subunits. Cell & Bioscience, Jul 2020. URL: https://doi.org/10.1186/s13578-020-00446-8, doi:10.1186/s13578-020-00446-8. This article has 70 citations and is from a peer-reviewed journal.

6. (herranzmontoya2021acomprehensiveanalysis pages 12-14): Irene Herranz-Montoya, Solip Park, and Nabil Djouder. A comprehensive analysis of prefoldins and their implication in cancer. iScience, 24:103273, Nov 2021. URL: https://doi.org/10.1016/j.isci.2021.103273, doi:10.1016/j.isci.2021.103273. This article has 24 citations and is from a peer-reviewed journal.

7. (OpenTargets Search: -PFDN4): Open Targets Query (-PFDN4, 1 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

8. (tahmaz2022prefoldinfunctionin pages 9-11): Ismail Tahmaz, Somayeh Shahmoradi Ghahe, and Ulrike Topf. Prefoldin function in cellular protein homeostasis and human diseases. Frontiers in Cell and Developmental Biology, Jan 2022. URL: https://doi.org/10.3389/fcell.2021.816214, doi:10.3389/fcell.2021.816214. This article has 48 citations and is from a poor quality or predatory journal.

## Citations

1. herranzmontoya2021acomprehensiveanalysis pages 1-2
2. herranzmontoya2021acomprehensiveanalysis pages 10-11
3. liang2020thefunctionsand pages 6-8
4. tahmaz2022prefoldinfunctionin pages 15-15
5. herranzmontoya2021acomprehensiveanalysis pages 12-14
6. tahmaz2022prefoldinfunctionin pages 9-11
7. herranzmontoya2021acomprehensiveanalysis pages 8-10
8. https://doi.org/10.1016/j.isci.2021.103273
9. https://doi.org/10.1186/s13578-020-00446-8
10. https://doi.org/10.3389/fcell.2021.816214
11. https://doi.org/10.1371/journal.pgen.1009183
12. https://doi.org/10.1186/s13578-020-00446-8.
13. https://doi.org/10.3389/fcell.2021.816214.
14. https://doi.org/10.1371/journal.pgen.1009183.
15. https://doi.org/10.1016/j.isci.2021.103273,
16. https://doi.org/10.3389/fcell.2021.816214,
17. https://doi.org/10.1186/s13578-020-00446-8,